Advertisement
Advertisement
U.S. markets open in 2 hours 38 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Vifor Pharma AG (VIFN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
116.50-7.30 (-5.90%)
As of 12:37PM CEST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in CHF

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/25/2021
Current
Market Cap (intraday) 5
8.08B
Enterprise Value 3
7.51B
Trailing P/E
38.10
Forward P/E 1
18.90
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
4.71
Price/Book (mrq)
2.40
Enterprise Value/Revenue 3
4.37
Enterprise Value/EBITDA 7
12.62

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 321.83%
S&P500 52-Week Change 339.86%
52 Week High 3140.10
52 Week Low 399.68
50-Day Moving Average 3123.15
200-Day Moving Average 3127.27

Share Statistics

Avg Vol (3 month) 3161.02k
Avg Vol (10 day) 3139.63k
Shares Outstanding 564.86M
Implied Shares Outstanding 6N/A
Float 846.85M
% Held by Insiders 127.48%
% Held by Institutions 138.54%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 41.61%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 31.62%
5 Year Average Dividend Yield 41.51
Payout Ratio 461.16%
Dividend Date 3May 12, 2021
Ex-Dividend Date 4May 10, 2021
Last Split Factor 210:1
Last Split Date 3May 22, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Jun 30, 2021

Profitability

Profit Margin 23.74%
Operating Margin (ttm)21.51%

Management Effectiveness

Return on Assets (ttm)4.80%
Return on Equity (ttm)8.91%

Income Statement

Revenue (ttm)1.75B
Revenue Per Share (ttm)27.00
Quarterly Revenue Growth (yoy)-1.00%
Gross Profit (ttm)1.06B
EBITDA 514M
Net Income Avi to Common (ttm)213.3M
Diluted EPS (ttm)6.40
Quarterly Earnings Growth (yoy)83.20%

Balance Sheet

Total Cash (mrq)626.2M
Total Cash Per Share (mrq)9.66
Total Debt (mrq)605.9M
Total Debt/Equity (mrq)16.10
Current Ratio (mrq)2.96
Book Value Per Share (mrq)52.03

Cash Flow Statement

Operating Cash Flow (ttm)441M
Levered Free Cash Flow (ttm)146.79M
Advertisement
Advertisement